MarketLens
Sign Up

Is Arrowhead Pharmaceuticals on the Cusp of a Major Breakout

5 months ago
SHARE THIS ON:

Is Arrowhead Pharmaceuticals on the Cusp of a Major Breakout

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Arrowhead Pharmaceuticals Director Sells 11,600 Shares for $1 Million

Arrowhead Pharmaceuticals director sold 11,600 shares for $1 million, reducing direct holdings by 9%. The insider sale may signal mixed sentiment ahead of upcoming clinical data readouts.
Stock News•2 months ago

Arrowhead: Stock Up On SHTG Data - No Ceiling On Valuation Growth Potential

Arrowhead Pharmaceuticals rose ~20% after Phase 3 plozasiran data showed 79–81% triglyceride reductions and lower acute pancreatitis risk, with regulatory filings planned before year-end.
Stock News•3 months ago

Why This Pharmaceutical Stock Jumped Close to 100% This Week

Shares of a pharmaceutical stock surged nearly 100% this week after agreeing to be acquired by a larger sector firm.

Breaking News

View All →

Top Headlines

View More →
Stock News•49 minutes ago

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•1 hour ago

Prediction: Alphabet Will Soar After Oct. 28

Stock News•1 hour ago

Alphabet (GOOGL) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News•1 hour ago

Why Alphabet Inc. (GOOG) Dipped More Than Broader Market Today

Stock News•2 hours ago

OpenAI claims ex-employee brought confidential docs about ‘unreleased device' to Apple